BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3104790)

  • 1. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.
    O'Brien RL; Brinster RL; Storb U
    Nature; 1987 Mar 26-Apr 1; 326(6111):405-9. PubMed ID: 3104790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
    Roes J; Hüppi K; Rajewsky K; Sablitzky F
    J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
    Rada C; González-Fernández A; Jarvis JM; Milstein C
    Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice.
    Suárez E; Magadán S; Sanjuán I; Valladares M; Molina A; Gambón F; Díaz-Espada F; González-Fernández A
    Mol Immunol; 2006 Apr; 43(11):1827-35. PubMed ID: 16343622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic hypermutation of the JC intron is markedly reduced in unrearranged kappa and H alleles and is unevenly distributed in rearranged alleles.
    Weber JS; Berry J; Litwin S; Claflin JL
    J Immunol; 1991 May; 146(9):3218-26. PubMed ID: 1901897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus.
    Carmack CE; Camper SA; Mackle JJ; Gerhard WU; Weigert MG
    J Immunol; 1991 Sep; 147(6):2024-33. PubMed ID: 1909739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
    Mastache EF; Lindroth K; Fernández C; González-Fernández A
    Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic hypermutation of an artificial test substrate within an Ig kappa transgene.
    Klotz EL; Hackett J; Storb U
    J Immunol; 1998 Jul; 161(2):782-90. PubMed ID: 9670955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of immunoglobulin delta chain causes allelic exclusion in transgenic mice.
    Iglesias A; Lamers M; Köhler G
    Nature; 1987 Dec 3-9; 330(6147):482-4. PubMed ID: 3120014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of somatic mutation in a kappa light chain transgene.
    Sharpe MJ; Neuberger M; Pannell R; Surani MA; Milstein C
    Eur J Immunol; 1990 Jun; 20(6):1379-85. PubMed ID: 2115000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recurrent clonotype in the spontaneous anti-IgG2a rheumatoid factor response of lpr/lpr mice.
    Hande S; Jacobson BA; Manser T
    J Immunol; 1996 Mar; 156(5):1856-64. PubMed ID: 8596037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in Ig V(D)J genes are distributed asymmetrically and independently of the position of V(D)J.
    Weber JS; Berry J; Manser T; Claflin JL
    J Immunol; 1994 Oct; 153(8):3594-602. PubMed ID: 7930582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic hypermutation in 5' flanking regions of heavy chain antibody variable regions.
    Rothenfluh HS; Taylor L; Bothwell AL; Both GW; Steele EJ
    Eur J Immunol; 1993 Sep; 23(9):2152-9. PubMed ID: 8370398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.